Abd El Bagi ME (2003) New radiographic classification of bone involvement in pedal mycetoma. AJR Am J Roentgenol 180(3):665–668

PubMed  Google Scholar 

Abugessaisa I, Konings M, Manabe R-I, Kawashima T, Hasegawa A, Takahashi C, Tagami M, Okazaki Y, Lim W, Verbon A, Fahal AH, Kasukawa T, van de Sande WWJ (2022) Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella. bioRxiv:2022.12.20.520897. https://doi.org/10.1101/2022.12.20.520897

Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A (2004) Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4(9):566–574

PubMed  Google Scholar 

Ahmed SA, González GM, Tirado-Sánchez A, Moreno-López LM, de Hoog S, Bonifaz A (2018) Nigrograna mackinnonii, not Trematosphaeria grisea (syn., Madurella grisea), is the main agent of black grain eumycetoma in Latin America. J Clin Microbiol. https://doi.org/10.1128/JCM.01723-17

PubMed  PubMed Central  Google Scholar 

Borelli C, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, Tiemann R, Tietjen K, Fugmann B, Lang-Fugmann S, Korting HC (2008) Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy 54(4):245–259

PubMed  PubMed Central  CAS  Google Scholar 

Browne N, Heelan M, Kavanagh K (2013) An analysis of the structural and functional similarities of insect hemocytes and mammalian phagocytes. Virulence 4(7):597–603

PubMed  PubMed Central  Google Scholar 

Cárdenas-de la Garza JA, Welsh O, Cuéllar-Barboza A, Suarez-Sánchez KP, De la Cruz-Valadez E, Cruz-Gómez LG, Gallardo-Rocha A, Ocampo-Candiani J, Vera-Cabrera L (2020) Clinical characteristics and treatment of actinomycetoma in northeast Mexico: a case series. PLoS Negl Trop Dis 14(2):e0008123

PubMed  PubMed Central  Google Scholar 

CDC (2024a) Clinical Overview of Mycetoma. PUblisher. https://archive.cdc.gov/www_cdc_gov/fungal/diseases/mycetoma/health-professionals.html#:~:text=Eumycetoma%20is%20less%20responsive%20to,cultured%20from%20lesions%20post%2Dtreatment. Accessed 25/03 2025

CDC (2024b) Mycetoma Basics. PUblisher. https://www.cdc.gov/mycetoma/about/index.html Accessed 25/03 2025

Clark JE, Kim HY, van de Sande WWJ, McMullan B, Verweij P, Alastruey-Izquierdo A, Chakrabarti A, Harrison TS, Bongomin F, Hay RJ, Oladele R, Heim J, Beyer P, Galas M, Siswanto S, Dagne DA, Roitberg F, Gigante V, Beardsley J, Sati H, Alffenaar JW, Morrissey CO (2024) Eumycetoma causative agents: a systematic review to inform the World Health Organization priority list of fungal pathogens. Med Mycol. https://doi.org/10.1093/mmy/myae044

PubMed  PubMed Central  Google Scholar 

ClinicalTrials.gov (2015) F901318 Single Ascending Dose Study in Healthy Male Volunteers. PUblisher. https://www.clinicaltrials.gov/study/NCT02142153?cond=olorofim&page=2&rank=16&tab=results. Accessed 01-08-2025

ClinicalTrials.gov (2024) Olorofim Aspergillus Infection Study (OASIS). PUblisher. https://www.clinicaltrials.gov/study/NCT05101187?cond=olorofim&page=1&rank=1. Accessed 01-08-2025

Crabol Y, Poiree S, Bougnoux ME, Maunoury C, Barete S, Zeller V, Arvieux C, Pineau S, Amazzough K, Lecuit M, Lanternier F, Lortholary O, French Mycosis Study G (2014) Last generation triazoles for imported eumycetoma in eleven consecutive adults. PLoS Negl Trop Dis 8(10):e3232

PubMed  PubMed Central  Google Scholar 

Dogra N, Kumar A, Mukhopadhyay T (2018) Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways. Sci Rep 8(1):11926

PubMed  PubMed Central  Google Scholar 

El-Amin SO, El-Amin RO, El-Sadig SM, Fahal AH, Musa A (2024) Painful mycetoma: a study to understand the risk factors in patients visiting the Mycetoma Research Centre (MRC) in Khartoum, Sudan. Trans R Soc Trop Med Hyg. https://doi.org/10.1093/trstmh/trae093

Google Scholar 

Elkheir LYM, Haroun R, Mohamed MA, Fahal AH (2020) Madurella mycetomatis causing eumycetoma medical treatment: the challenges and prospects. PLoS Negl Trop Dis 14(8):e0008307

PubMed  PubMed Central  Google Scholar 

Emery D, Denning DW (2020) The global distribution of actinomycetoma and eumycetoma. PLoS Negl Trop Dis 14(9):e0008397

PubMed  PubMed Central  Google Scholar 

Fahal AH, Bakhiet SM (2023) Mycetoma and the environment. PLoS Negl Trop Dis 17(11):e0011736

PubMed  PubMed Central  Google Scholar 

Fahal AH, Rahman IA, El-Hassan AM, Rahman ME, Zijlstra EE (2011) The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg 105(3):127–132

PubMed  CAS  Google Scholar 

Fahal A, el Mahgoub S, El Hassan AM, Abdel-Rahman ME (2015) Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan. PLoS Negl Trop Dis 9(3):e0003679

PubMed  PubMed Central  Google Scholar 

Fahal AH, Suliman SH, Hay R (2018) Mycetoma: the spectrum of clinical presentation. Trop Med Infect Dis. https://doi.org/10.3390/tropicalmed3030097

PubMed  PubMed Central  Google Scholar 

Fahal AH, Ahmed ES, Bakhiet SM, Bakhiet OE, Fahal LA, Mohamed AA, Mohamedelamin ESW, Bahar MEN, Attalla HY, Siddig EE, Mhmoud NA, Musa AM, van de Sande WWJ, Scherrer B, Oyieko P, Egondi TW, Onyango KO, Hata K, Chu WY, Dorlo TPC, Brüggemann RJ, Nyaoke BA, Strub-Wourgaft N, Zijlstra EE (2024) Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial. Lancet Infect Dis 24(11):1254–1265

PubMed  CAS  Google Scholar 

Feuss A, Bougnoux ME, Dannaoui E (2024) The role of Olorofim in the treatment of filamentous fungal infections: a review of in vitro and in vivo studies. J Fungi. https://doi.org/10.3390/jof10050345

Google Scholar 

Gismalla MDA, Bakhiet MY, Alshareef AM, Saadeldien MSM, Ahmed GMA, Adam AMI, Abuelnour AEK (2024) Reconstructive surgery for mycetoma: preliminary algorithm and a systematic review. JPRAS Open 40:130–137

PubMed  PubMed Central  Google Scholar 

Hassan R, Simpson H, Cano J, Bakhiet S, Ganawa E, Argaw D, Newport MJ, Deribe K, Fahal AH (2021) Modelling the spatial distribution of mycetoma in Sudan. Trans R Soc Trop Med Hyg 115(10):1144–1152

PubMed  PubMed Central  Google Scholar 

Herrick EJ, Patel P, Hashmi MF (2025) Antifungal ergosterol synthesis inhibitors. In: StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK551581/

Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW (2013) A histopathological exploration of the Madurella mycetomatis grain. PLoS One 8(3):e57774

PubMed  PubMed Central  CAS  Google Scholar 

Kloezen W, van Helvert-van PM, Fahal AH, van de Sande WW (2015) A Madurella mycetomatis grain model in Galleria mellonella larvae. PLoS Negl Trop Dis 9(7):e0003926

PubMed  PubMed Central  Google Scholar 

Konings M, Eadie K, Strepis N, Nyuykonge B, Fahal AH, Verbon A, van de Sande WWJ (2023) The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo. Med Mycol. https://doi.org/10.1093/mmy/myad118

PubMed  PubMed Central  Google Scholar 

Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf 16(2):149–165

PubMed  CAS  Google Scholar 

Laniado-Laborín R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26(4):223–227

PubMed  Google Scholar 

Lim W, Melse Y, Konings M, Phat Duong H, Eadie K, Laleu B, Perry B, Todd MH, Ioset JR, van de Sande WWJ (2018) Addressing the most neglected diseases through an open research model: the discovery of fenarimols as novel drug candidates for eumycetoma. PLoS Negl Trop Dis 12(4):e0006437

PubMed  PubMed Central  Google Scholar 

Lim W, Konings M, Parel F, Eadie K, Strepis N, Fahal A, Verbon A, van de Sande WWJ (2022) Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella. Med Mycol. https://doi.org/10.1093/mmy/myac003

PubMed  PubMed Central  Google Scholar 

Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, Bonifaz A, Todd M, Perry B, Samby K, Burrows J, Verbon A, van de Sande W (2022) Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma. PLoS Negl Trop Dis 16(2):e0010159

PubMed  PubMed Central  CAS  Google Scholar 

Lim W, Verbon A, van de Sande W (2022) Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an open source drug discovery approach. Expert Opin Drug Discov 17(6):641–659

PubMed  CAS  Google Scholar 

Ma J, Konings M, Verbon A, van de Sande WWJ (2023) A Falciformispora senegalensis grain model in Galleria mellonella larvae. Med Mycol. https://doi.org/10.1093/mmy/myad070

PubMed  PubMed Central  Google Scholar 

Ma J, Eadie K, Schippers M, Fahal A, Laleu B, Verbon A, van de Sande WWJ (2024) Novel compound MMV1804559 from the global health priority box exhibits in vitro and in vivo activity against Madurella mycetomatis. Int J Mol Sci 25(11):6227. https://doi.org/10.3390/ijms25116227

PubMed  PubMed Central  CAS  Google Scholar 

Ma J, Eadie K, Konings M, Fahal A, Verbon A, Van de Sande WJ (2025) Ibrexafungerp prolongs survival and reduces theeumycetoma grain size in Galleria mellonella infection models of two different causative agents of eumycetoma. J Antimicrob Chemother 80(6):1733–1741. https://doi.org/10.1093/jac/dkaf133

PubMed  PubMed Central  CAS  Google Scholar 

Nakano M, Aoki Y, Yamaguchi H (2019) [Drug properties of fosravuconazole L-lysine ethanolate (NAILIN(®) capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data]. Nihon Yakurigaku Zasshi 153(2):79–87